Site icon SEMS-journal

Physical activity and exercise training in preventive cardiology

Trachsel LD
Präventive Kardiologie & Sportmedizin, Universitätsklinik für Kardiologie, Inselspital, Universitätsspital Bern

Abstract

Physical activity (PA) and exercise training (ET) are central and indispensable components for primary and secondary prevention of cardiovascular disease (CVD). In healthy individuals, PA reduces all-cause and CV mortality and has confirmed beneficial effects on the cardiovascular risk profile. In secondary prevention, PA counselling und ET are two of the core components of a multidisciplinary cardiac rehabilitation (CR) program. Exercise-based CR is an established strategy in the secondary prevention of CV disease. It improves survival, reduces hospital admissions, improves cardiorespiratory fitness (CRF), and quality of life (QoL). However, these beneficial effects require regular attendance under professional supervision and adherence to recommended guidelines. In patients with heart disease, proper patient assessment with a standardized exercise test as a basis for a tailored ET prescription is required. In healthy subjects this is advocated only in selected groups.
Current guidelines recommend at least 150 min/week of moderate-intensity continuous aerobic PA in both healthy individuals as well as those with cardiac disease. In healthy adults, alternatively intensity can be increased and volume can be halved. High intensity interval training (HIIT) is a relatively new training modality and may be used complementary to continuous training in selected patient groups. HIIT seems to be superior compared to moderate continuous exercise in patients with cardio metabolic disease with regard to effects on the CV risk profile, endothelial function, improvement in cardiorespiratory fitness, and a reverse cardiac remodelling in patients with heart failure.
One of the major challenges in preventive cardiology is the improvement of long-term adherence to PA recommendations. The aim of this article is to give an overview from the preventive cardiologist’s point of view with a focus on endurance ET prescription for the audience of sports and exercise medicine physicians.

Zusammenfassung

Körperliche Aktivität und strukturiertes Training sind zentrale und unabdingbare Komponenten in der kardiovaskulären Primär- und Sekundärprävention. Bei Gesunden reduziert körperliche Aktivität die kardiovaskuläre und Gesamtmortalität mit günstigem Einfluss auf das kardiovaskuläre Risikoprofil. In der Sekundärprävention sind Beratung bezüglich körperlicher Aktivität und strukturiertes Training zwei der Kernkomponenten eines multidisziplinären kardialen Rehabilitationsprogrammes. Bewegungs-basierte kardiale Rehabilitationsprogramme sind eine etablierte Strategie in der kardiovaskulären Prävention. Sie senken die Mortalität, verhindern Rehospitalisationen, verbessern die kardiorespiratorische Fitness und die Lebensqualität. Voraussetzung ist eine regelmässige Teilnahme, eine professionelle Supervision des Trainings und die Einhaltung der generellen Bewegungs-Empfehlungen. Bei Patienten mit einer Herzerkrankung ist eine Standortbestimmung mittels standardisierten Belastungstests als Basis für ein massgeschneidertes Training von Bedeutung. Bei Gesunden wird dies nur in speziellen Fällen empfohlen.
Die aktuellen Richtlinien empfehlen mindestens 150 Minuten/Woche moderat-kontinuierliche körperliche Aktivität sowohl für Gesunde wie auch für Patienten mit einer Herzerkrankung. Als Alternative kann bei Gesunden die Intensität erhöht und stattdessen die Dauer halbiert werden. Hochintensives Intervalltraining (HIIT) stellt bei speziellen Patientengruppen eine relativ neue Trainingsmodalität dar, die komplementär zum etablierten kontinuierlich-moderaten Training angesehen wird. Studien zeigen, dass HIIT der etablierten moderat-kontinuierlichen Trainingsmodalität überlegen sein könnte in Bezug auf Effekte auf das kardiovaskuläre Risikoprofil, die Endothelfunktion, die Verbesserung der kardiorespiratorischen Fitness und nicht zuletzt in Bezug auf den Effekt auf das kardiale Remodelling bei Herzinsuffi­zienz.
Eine der grössten zukünftigen Herausforderungen der Präventiven Kardiologie ist die Verbesserung der Langzeitadhärenz bezüglich Einhaltung der Bewegungsempfehlungen. Dieser Artikel soll eine Übersicht geben aus Sicht der Präventiven Kardiologie mit speziellem Fokus auf Verschreibung von Ausdauertraining für die Leserschaft aus dem Bereich der Sport- und Bewegungsmedizin.

Introduction

“Lack of activity destroys the good condition of every human being, while movement and methodical physical exercise save it and preserve it.” Plato, Greek philosopher

Cardiovascular disease (CVD) remains the leading global cause of death, accounting for 17.3 million deaths per year worldwide. [1] Physical inactivity has been identified as one of the leading risk factors for global mortality causing an estimated 3.2 million premature deaths globally. [2] Physical activity (PA) is defined as any body movement produced by the contraction of skeletal muscles that results in a substantial increase in caloric requirement over resting energy expenditure. [3,4] In 1953, Morris and colleagues showed that London’s double-decker bus drivers had a higher rate of coronary events compared to conductors. This was attributed to the physically more active job of the conductors compared to the physically inactive bus drivers. [5] This seminal study was the first who confirmed the beneficial effects of PA in cardiovascular (CV) health. Nowadays, multiple population-based trials have confirmed that there is an inverse correlation between PA and all-cause/CV mortality: even doses as low as 15 min of PA per day appear to reduce CV disease risk and all-cause mortality with the greatest health gains due to the first 15–29 min of daily activity in previously inactive individuals. [6–8] A recently published study found a strong negative association of cardiorespiratory fitness (CRF) level in middle aged healthy subjects with health care costs later in life. [9] Over the last six decades the concept that PA and/or structured exercise training (ET) reduce CV mortality has been extended to patients with manifest heart disease (i.e. patients with coronary artery disease (CAD), after percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), and heart failure (HF) patients). [10] ET is a type of PA consisting of planned, structured, and repetitive bodily movement done to improve and/or maintain CRF. [3,4] Cardiac rehabilitation (CR) has the potential to improve survival and reduce hospital admissions, if attended on a regular basis. [11] Exercise-based CR is an established strategy in the secondary prevention of CV disease.
In a large meta-analysis published this year, which collected follow-up data of 14,486 patients with CAD and included 63 prospective randomized clinical trials, exercise-based CR was associated with a substantial reduction in cardiovascular mortality and hospital admissions. The majority of analysed studies showed higher levels of health-related quality of life (QoL) following exercise-based CR compared to control subjects. [12] However, achievement of sustainable effects on hard end-points have been challenged recently. Amongst other studies from the United Kingdom (UK), the RAMIT trial is the largest randomized controlled trial on comprehensive CR after myocardial infarction. This trial has failed to show beneficial effects on all-cause mortality, cardiac or psychological morbidity, risk factors, health-related QoL or activity. [13] The study had major limitations. Besides being underpowered for the assessment of mortality, the prescribed ET volume was only half of what current recommendations state. Additionally, ET was not tailored based on a maximum exercise test, due to routine submaximal exercise testing in the UK at the entry of a CR program. Consequently, the overall increase in CRF was only about one third (0.52 MET, metabolic equivalent) of the mean increase reported in a recent meta-analysis (1.55 MET). These low training volumes and small increases in CRF may partially explain the reported inefficacy of UK CR to reduce patient mortality. [14–16]
In heart failure patients mortality reduction, reduction of re-hospitalization rate and the improvement in CRF is of utmost importance. [17,18] In a recent meta-analysis including 33 trials with 4740 HF patients, exercise-based CR revealed no increased risk of all-cause mortality compared to controls, but reduced the risk of hospital admissions and conferred improvements in health-related QoL. [19] Furthermore, two recent meta-analyses have emphasized the importance of aerobic endurance training on reverse left ventricular remodeling. [20,21] In chronic HF patients, the development of a catabolic metabolic state is another aspect of interest. Skeletal myopathy is a major limitation of exercise capacity. Muscle wasting is an independent predictor of mortality in CHF and is beneficially influenced by ET on a regular basis. [22,23] Most patients included in exercise-based HF studies had systolic dysfunction (HFrEF). However, ≈50% of patients with HF have heart failure with preserved ejection fraction (HFpEF), which is particularly common in older patients with HF and in women. [24,25] Mortality data in HFpEF patients are currently lacking. Recent data revealed that ET in patients with HFpEF is associated with an improvement in CRF and QoL. [26] The ExDHF study demonstrated that a structured ET in patients with HFpEF has additional beneficial effects on LV diastolic function compared to patients who received usual care. [27] Taking all these aspects into account, it is comprehensible that PA counselling and a tailored as well as an initially supervised ET are two of the core components of a multidisciplinary secondary prevention program. [28]

Physiological effect of exercise

The beneficial effects of exercise on CV risk factors like body composition, blood pressure, blood glucose and lipid profile are well known. [29–32] There seems to be an intensity-dependent effect with more favorable effects regarding body composition, visceral fat and lipid profile at higher exercise intensities. [33,34] Other aspects of interest are the molecular changes that occur in the CV system in response to ET. A byproduct of regular physical exercise is the increase in shear stress of blood flowing through the main arteries leading to the production of vascular nitric oxide (NO) by the up-regulation of endothelial nitric oxide synthase (eNOS). [35] NO induces vasodilation, which results in the lowering of peripheral resistance and increased perfusion of the skeletal muscles. Furthermore, endothelial progenitor cells are activated by ET, which preserve normal endothelial function and stimulate vasculogenesis, and induce multiple metabolic changes in the myocardium resulting in improved tolerance for ischemia and reperfusion injury. [36–40] Last but not least, arterial stiffness, which is associated with several pathologies like systolic hypertension and HF is lower in subjects who regularly exercise compared to sedentary controls. [41,42]

Risk assessment and Exercise testing

In healthy subjects aiming to participate in regular PA – particularly those aged 35 years or older- a self-assessment of the habitual PA level, for example using a validated questionnaire (i.e. Physical Activity Readiness Questionnaire, PAR-Q) and of the risk factors for CAD (for Switzerland based on the AGLA-Score) is recommended for screening. [43–45] Individuals deemed to be at risk require further evaluation by a qualified physician, additional maximal exercise testing and possibly further evaluation is advocated. The results of a maximal exercise test supply individuals with adequate and personalized recommendations for appropriate training intensities. [46] Proper patient assessment, which includes a direct evaluation of exercise capacity, is an essential core component before the inclusion of a patient in a secondary prevention program. [47] The gold standard is a symptom -limited incremental standard exercise test (bicycle, treadmill), which allows direct or indirect determination of exercise intensity, as a basis for a tailored ET prescription. [28,48] Exercise intensity is strictly and causally linked to energy expenditure during effort. In an oxygen-dependent biological system, the latter is mostly described by oxygen uptake (VO2) through the O2 energy equivalent. As a consequence, peak VO2 and the first and second ventilatory thresholds (i.e. the physiological descriptors of the O2 transport and utilization system response to exercise) are the gold standard references for the evaluation of aerobic metabolism function and, consequently, for aerobic exercise intensity assessment and prescription. [49–53] Direct measurement of respiratory gases via a cardio-pulmonary exercise test (CPET) is recommended in the following cardiac patients groups for prognostic and diagnostic stratification: patients with HF (HFrEF, HFpEF), congenital heart disease, pulmonary hypertension and cardiomyopathy (such as hypertrophic cardiomyopathy). [54]

Cardiorespiratory fitness as surrogate marker of mortality

Cardiorespiratory fitness (CRF, measured as peak VO2) is a marker of aerobic exercise capacity and can be expressed as metabolic equivalents (MET), with 1 MET corresponding to 3.5 mL of oxygen per kilogram of body weight per minute (mL/kg/min), the typical resting energy requirement for basal homeostasis.
In addition, CRF is an important surrogate marker of survival and well-being in healthy subjects and those with CV disease, respectively. There is an inverse correlation of CRF and mortality. [55] Each 1-MET increase in CRF is associated with a significant reduction in mortality and CAD events, which compares favorably with the survival benefit conferred by low-dose aspirin, statins, Beta-blockers, and angiotensin-converting enzyme inhibitors after acute myocardial infarction. [56,57]

Table 1: FITT-VP principle for exercise prescription [4]

Exercise prescription

The principles of PA promotion and ET prescription are intended to guide health/fitness on the one hand, and to individually tailor ET for the apparently healthy adult as well as adults with certain chronic (cardiac) diseases on the other. The American College of Sports Medicine (ACSM) recommends in its companion evidence-based position stand to employ the FITT-VP principle to prescribe ET (Table 1). [4]Intensity guidance can easily be made by self-assessment (e.g. rate of perceived exertion (RPE), i.e., “Borg Scale”). [58]Alternatively, peak heart rate (HR) can be determined with an incremental self-test. Based on this, training intensities can indirectly be calculated (Table 2). If CPET is available, the first and second ventilatory threshold can directly be determined. In summary, training should be guided based on workload and training zones and not on heart rate, particularly in cardiac patients.
Generally, PA promotion should be part of a structured lifestyle counselling program. [4,47] PA promotion as well as ET prescription is not only reserved to exercise physiologists and specialists in preventive medicine, but should also be done in the doctor’s office by general practitioners (GP) and sports and exercise physicians. In Switzerland, several institutions such as the Swiss society of Sports Medicine propose physical activity promotion in primary care (PAPRICA) to emphasize that GP’s play an essential role in PA promotion. [59]
In healthy adults, current European guidelines recommend an aerobic PA volume of 150–300min/week of at least ­moderate-intensity (Zone II, Table 2) to provide a reduction in all-cause and cardiovascular mortality. As a time-efficient alternative 60–90min/week of high-intensity may be performed, or an equivalent combination of the two types of training. [60] While PA in the primary preventive setting can be seen as an effective monotherapy, in secondary prevention it is in concert with optimal medical therapy which it cannot replace.
In patients with known CVD (including CAD, HF), aerobic ET is recognized as a class I, level of evidence A indication. [60] Among others, PA counselling and ET are two additional core components of a multidisciplinary CR program. [28] A moderate intensity continuous ET (i.e., starting at 50% of maximal work load and gradually increasing to 80% in CAD, and starting at the 1st and gradually increasing to the 2nd ventilatory threshold in HF patients, respectively, Figure 1A), scheduled as 30 min session 3–5 times per week, under close supervision are recommended. [47,60]
Additionally, there is growing evidence that high-intensity interval training (HIIT) may be equivalent or even more effective than moderate-intensity continuous exercise training (MICE) and can be performed safely with impressive improvements in CRF and QoL in CAD patients as well as in chronic HF patients, in whom reverse cardiac remodeling was found with HIIT. [61–64] In patients with lifestyle-induced cardio metabolic disease significant beneficial effects on the cardiovascular risk profile, oxidative stress and inflammation, as well as increases in the availability of NO by HIIT were shown. [65]
Currently, the most commonly used HIIT model consists of 4 times 4 min high intensity intervals (at 80% of maximal work load or above the 2nd ventilatory threshold) and active recovery phases of 3 min at low intensity (at 50% of maximal workload or below the 1st ventilatory threshold, Figure 1B). [49] The current recommendation is to use HIIT complementary, but not as a replacement for the more established MICE. [66]
In much deconditioned HF patients a low intensity interval training with short bouts (10 to 30 seconds, at 50% of maximal work load, or below the 1st ventilatory threshold) and longer recovery periods is recommended (Figure 1C). [66]
In patients with CAD, an additional resistance training (RT) seems to be more effective than endurance training alone. [67] Recommended is an expansion of endurance ET to a dynamic RT 2 times/week (not pure isometric training) in all clinically stable patients with and without HF. [66,68,69] A combined ET/RT does not lead to a cardiac remodeling with a more pronounced LV dilatation than ET alone. [70] In chronic HF patients, Inspiratory muscle weakness (IMW) is highly prevalent. In selected patients, the addition of inspiratory muscle training results in improvements in inspiratory muscle strength, CRF, ventilator response to exercise, and QoL. [71,72]

Table 2: Intensities for endurance training

Conclusions

PA and ET are central and indispensable components of a comprehensive strategy for the primary and secondary prevention of CAD. PA advice has to be part of a structured lifestyle counselling program and should increasingly take place in the doctor’s office and be promoted by general practitioners (GP), particularly in primary prevention. Current international PA recommendations should be applied which have been shown to result in sustainable effects. Exercise-based programs contribute to a decreased morbidity and mortality, particularly in patients with CAD with or without HF. Subjects/patients assessment need to be tailored and should include high quality ET recommendations and therapy, delivered by specialists in sports and exercise medicine. Continuous training and interval training can be used complementarily in patients with heart disease.

Figure 1: Different training types for patients with heart disease based on the three zone model (adapted from [49,52]): Zone I: low; Zone II: moderate; Zone III: high intensity zone

Perspective

One of the major challenges in preventive cardiology is the improvement of long-term adherence (’patient empowerment’). Adherence to behavioral advice is associated with a substantially lower risk of recurrent cardiovascular events, particularly regarding ET recommendations. [73] Future directions with great potential are home-based and smartphone-based CR programs. Comparing home- versus center-based CR programs, there seems to be no difference regarding mortality risk, improvement in CRF, as well as modifiable risk factors, and health-related QoL outcomes in patients with CAD or HF. Additionally, there is no difference with regard to healthcare costs produced by the two forms of cardiac rehabilitation. [74,75] The addition of cardiac tele-rehabilitation to conventional center-based CR may even be more effective and efficient than center-based CR alone, particularly with regard to sustainability of PA level. [76,77]
Practical implications
– Physical activity (PA) reduces all-cause and cardiovascular (CV) mortality and has beneficial effects on the car­diovascular risk profile in healthy individuals
– PA advice should increasingly take place in the doctor’s office and be promoted by general practitioners, particularly in primary prevention
– In secondary prevention, PA counselling und structured exercise training are two core components of a multidisciplinary cardiac rehabilitation (CR) program
– Exercise-based CR is an established strategy in the secondary prevention of CV disease and improves survival, reduces hospital admissions, improves cardiorespiratory fitness (CRF), and quality of life
– High intensity interval training (HIIT) can be used complementary to moderate continuous training and may be even superior in patients with cardio metabolic disease with regard to effects on the CV risk profile, endothelial function, improvement in CRF, and a reverse cardiac remodeling in patients with heart failure

Schlussfolgerungen für die Praxis

– Körperliche Aktivität ist beim Gesunden mit einer Mortalitätsreduktion und einem günstigen Einfluss auf das kardiovaskuläre Risikoprofil vergesellschaftet
– Die Beratung bezüglich körperlicher Aktivität sollte vermehrt auch in der Arztpraxis durch den Grundversorger stattfinden, speziell in der Primärprävention
– In der Sekundärprävention sind Beratung bezüglich körperlicher Aktivität und strukturiertes Training zwei Kernkomponenten eines multidisziplinären kardialen Rehabilitationsprogrammes
– Bewegungs-basierte kardiale Rehabilitationsprogramme sind etabliert in der Sekundärprävention und senken die Mortalität, verhindern Re-Hospitalisationen, verbessern die kardiorespiratorische Fitness und die Lebensqualität
– Hochintensives Intervalltraining (HIIT) kann komplementär zum etablierten moderat kontinuierlichen Training eingesetzt werden und könnte bei Patienten mit kardio-metabolischer Erkrankung gar überlegen sein in Bezug auf Effekte auf das kardiovaskuläre Risikoprofil, die Endothelfunktion, die Verbesserung der kardiorespiratorischen Fitness und nicht zuletzt in Bezug auf den Effekt auf das kardiale Remodelling bei Herzinsuffizienz

Acknowledgements

I appreciate the intellectual input and critical review of the manuscript by Prisca Eser (PhD) and Matthias Wilhelm (MD).

Conflict of interest: none declared

Corresponding author

Dr. med. Lukas D. Trachsel
Präventive Kardiologie & Sportmedizin
Universitätsklinik für Kardiologie
Inselspital, Universitätsspital Bern
3010 Bern
lukas.trachsel@insel.ch
Telefon +41 31 632 89 70
Fax +41 31 632 89 77

References

  1. Smith SC, Jr., Collins A, Ferrari R, Holmes DR, Jr., Logstrup S, McGhie DV, et al. Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke). Circulation. 2012;126(23):2769–75.
  2. Organization WH. Global recommendations on physical activity for health. (16.04.2016)
  3. Caspersen CJ, Powell KE, Christenson GM. Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep. 1985;100(2):126–31.
  4. Ls P. Acsm’S Guidelines for Exercise Testing and Prescription. ­American College Of Sports Medicine. 2012(9th Edition).
  5. Morris JN, Heady JA, Raffle PA, Roberts CG, Parks JW. Coronary heart-disease and physical activity of work. Lancet. 1953;265(6796):1111–20; concl.
  6. Wen CP, Wai JP, Tsai MK, Yang YC, Cheng TY, Lee MC, et al. Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study. Lancet. 2011;378(9798):1244–53.
  7. Wen CP, Wu X. Stressing harms of physical inactivity to promote exercise. Lancet. 2012;380(9838):192–3.
  8. Paffenbarger RS Jr HR, Wing AL, Hsieh CC. Physical Activity, All-Cause Mortality, and Longevity of College Alumni. N Engl J Med. 1986(314(10)):605–12.
  9. Bachmann JM, DeFina LF, Franzini L, Gao A, Leonard DS, Cooper KH, et al. Cardiorespiratory Fitness in Middle Age and Health Care Costs in Later Life. J Am Coll Cardiol. 2015;66(17):1876–85.
  10. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937–52.
  11. Martin BJ, Hauer T, Arena R, Austford LD, Galbraith PD, Lewin AM, et al. Cardiac rehabilitation attendance and outcomes in coronary artery disease patients. Circulation. 2012;126(6):677–87.
  12. Anderson L, Oldridge N, Thompson DR, Zwisler AD, Rees K, Martin N, et al. Exercise-Based Cardiac Rehabilitation for Coronary Heart Disease: Cochrane Systematic Review and Meta-Analysis. J Am Coll Cardiol. 2016;67(1):1–12.
  13. West RR, Jones DA, Henderson AH. Rehabilitation after myocardial infarction trial (RAMIT). Heart. 2013;99(2):146.
  14. Sandercock GR, Cardoso F, Almodhy M, Pepera G. Cardiorespiratory fitness changes in patients receiving comprehensive outpatient cardiac rehabilitation in the UK: a multicentre study. Heart. 2013;99(11):785–90.
  15. Sandercock G, Hurtado V, Cardoso F. Changes in cardiorespiratory fitness in cardiac rehabilitation patients: a meta-analysis. Int J Cardiol. 2013;167(3):894–902.
  16. Pattyn N, Coeckelberghs E, Buys R, Cornelissen VA, Vanhees L. Aerobic interval training vs. moderate continuous training in coronary artery disease patients: a systematic review and meta-analysis. Sports Med. 2014;44(5):687–700.
  17. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. European heart journal. 2012;33(14):1787–847.
  18. Hambrecht R, Niebauer J, Fiehn E, Kalberer B, Offner B, Hauer K, et al. Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles. J Am Coll Cardiol. 1995;25(6):1239–49.
  19. Taylor RS, Sagar VA, Davies EJ, Briscoe S, Coats AJ, Dalal H, et al. Exercise-based rehabilitation for heart failure. Cochrane Database Syst Rev. 2014;4:CD003331.
  20. Haykowsky M, Scott J, Esch B, Schopflocher D, Myers J, Paterson I, et al. A meta-analysis of the effects of exercise training on left ventricular remodeling following myocardial infarction: start early and go longer for greatest exercise benefits on remodeling. Trials. 2011;12:92.
  21. Haykowsky MJ, Liang Y, Pechter D, Jones LW, McAlister FA, Clark AM. A meta-analysis of the effect of exercise training on left ventricular remodeling in heart failure patients: the benefit depends on the type of training performed. Journal of the American College of Cardiology. 2007;49(24):2329–36.
  22. Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet. 1997;349(9058):1050–3.
  23. Middlekauff HR. Making the case for skeletal myopathy as the major limitation of exercise capacity in heart failure. Circ Heart Fail. 2010;3(4):537–46.
  24. Kitzman DW. Exercise training in heart failure with preserved ejection fraction: beyond proof-of-concept. J Am Coll Cardiol. 2011;58(17):1792–4.
  25. Haykowsky MJ, Brubaker PH, John JM, Stewart KP, Morgan TM, Kitzman DW. Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction. J Am Coll Cardiol. 2011;58(3):265–74.
  26. Pandey A, Parashar A, Kumbhani DJ, Agarwal S, Garg J, Kitzman D, et al. Exercise training in patients with heart failure and preserved ejection fraction: meta-analysis of randomized control trials. Circ Heart Fail. 2015;8(1):33–40.
  27. Edelmann F, Gelbrich G, Dungen HD, Frohling S, Wachter R, Stahrenberg R, et al. Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study. J Am Coll Cardiol. 2011;58(17):1780–91.
  28. European Association of Cardiovascular P, Rehabilitation Committee for Science G, Eacpr, Corra U, Piepoli MF, Carre F, et al. Secondary prevention through cardiac rehabilitation: physical activity counselling and exercise training: key components of the position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur Heart J. 2010;31(16):1967–74.
  29. Fagard RH. Exercise characteristics and the blood pressure response to dynamic physical training. Med Sci Sports Exerc. 2001;33(6 Suppl):S484–92; discussion S93–4.
  30. Umpierre D, Ribeiro PA, Kramer CK, Leitao CB, Zucatti AT, Azevedo MJ, et al. Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis. JAMA. 2011;305(17):1790–9.
  31. Leon AS, Sanchez OA. Response of blood lipids to exercise training alone or combined with dietary intervention. Med Sci Sports Exerc. 2001;33(6 Suppl):S502-15; discussion S28–9.
  32. Sieverdes JC, Sui X, Lee DC, Church TS, McClain A, Hand GA, et al. Physical activity, cardiorespiratory fitness and the incidence of type 2 diabetes in a prospective study of men. Br J Sports Med. 2010;44(4):238–44.
  33. Irving BA, Davis CK, Brock DW, Weltman JY, Swift D, Barrett EJ, et al. Effect of exercise training intensity on abdominal visceral fat and body composition. Med Sci Sports Exerc. 2008;40(11):1863–72.
  34. Cornelissen VA, Verheyden B, Aubert AE, Fagard RH. Effects of aerobic training intensity on resting, exercise and post-exercise blood pressure, heart rate and heart-rate variability. J Hum Hypertens. 2010;24(3):175–82.
  35. Busconi L, Michel T. Endothelial nitric oxide synthase. N-terminal myristoylation determines subcellular localization. J Biol Chem. 1993;268(12):8410–3.
  36. Schuler G, Adams V, Goto Y. Role of exercise in the prevention of cardiovascular disease: results, mechanisms, and new perspectives. European heart journal. 2013;34(24):1790–9.
  37. Gielen S, Schuler G, Hambrecht R. Exercise training in coronary artery disease and coronary vasomotion. Circulation. 2001;103(1):E1-6.
  38. Gielen S, Hambrecht R. Effects of exercise training on vascular function and myocardial perfusion. Cardiol Clin. 2001;19(3):357–68.
  39. Gielen S, Schuler G, Adams V. Cardiovascular effects of exercise training: molecular mechanisms. Circulation. 2010;122(12):1221–38.
  40. Laughlin MH, Bowles DK, Duncker DJ. The coronary circulation in exercise training. Am J Physiol Heart Circ Physiol. 2012;302(1):H10–23.
  41. Arnett DK, Evans GW, Riley WA. Arterial stiffness: a new cardiovascular risk factor? Am J Epidemiol. 1994;140(8):669–82.
  42. Tanaka H, Dinenno FA, Monahan KD, Clevenger CM, DeSouza CA, Seals DR. Aging, habitual exercise, and dynamic arterial compliance. Circulation. 2000;102(11):1270–5.
  43. Borjesson M, Urhausen A, Kouidi E, Dugmore D, Sharma S, Halle M, et al. Cardiovascular evaluation of middle-aged/ senior individuals engaged in leisure-time sport activities: position stand from the sections of exercise physiology and sports cardiology of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil. 2011;18(3):446–58.
  44. Cardinal BJ, Esters J, Cardinal MK. Evaluation of the revised physical activity readiness questionnaire in older adults. Med Sci Sports Exerc. 1996;28(4):468–72.
  45. David Nanchen AvE, Walter F. Riesen, Hans-Jürg Beer, David Conen, David Carballo, Roger Darioli, Richard James, François Mach, Rubino Mordasini, Nicolas Rodondi im Namen der Schweizer Arbeitsgruppe Lipide und Atherosklerose (AGLA). Cholesterinmanagement in der kardiovaskulären Risikoprävention: amerikanische Guidelines 2013, Stellungnahme der Schweizer Arbeitsgruppe Lipide und Atherosklerose (AGLA). Schweiz Med Forum. 2014(14(19)):378–81.
  46. Fletcher GF, Ades PA, Kligfield P, Arena R, Balady GJ, Bittner VA, et al. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation. 2013;128(8):873–934.
  47. Piepoli MF, Corra U, Benzer W, Bjarnason-Wehrens B, Dendale P, Gaita D, et al. Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil. 2010;17(1):1–17.
  48. Guazzi M, Adams V, Conraads V, Halle M, Mezzani A, Vanhees L, et al. EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation. 2012;126(18):2261–74.
  49. Mezzani A, Hamm LF, Jones AM, McBride PE, Moholdt T, Stone JA, et al. Aerobic exercise intensity assessment and prescription in cardiac rehabilitation: a joint position statement of the European Association for Cardiovascular Prevention and Rehabilitation, the American Association of Cardiovascular and Pulmonary Rehabilitation and the Canadian Association of Cardiac Rehabilitation. Eur J Prev Cardiol. 2013;20(3):442–67.
  50. Wasserman K HJ, Sue DY, Whipp BJ, Casaburi R. Principles of exercise testing and interpretation, . Williams & Wilkins. 2012;5th edition.
  51. Wasserman K WB, Koyl SN, Beaver WL. Anaerobic threshold and respiratory gas exchange during exercise. J. J Appl Physiol. 1973;35.
  52. M. Vogt Ob, R. Schütz, J. Wehrlin, C. Perret, R. Umberg, U. Aeschlimann, U. Bodenmann, S. Matter, A. Bürgi. Physiologische Trainings­intensitätszonen. Fachdokumentation 2005/1. 2005.
  53. Binder RK, Wonisch M, Corra U, Cohen-Solal A, Vanhees L, Saner H, et al. Methodological approach to the first and second lactate threshold in incremental cardiopulmonary exercise testing. Eur J Cardiovasc Prev Rehabil. 2008;15(6):726–34.
  54. Guazzi M, Adams V, Conraads V, Halle M, Mezzani A, Vanhees L, et al. EACPR/AHA Joint Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Eur Heart J. 2012;33(23):2917–27.
  55. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346(11):793–801.
  56. Kodama S, Saito K, Tanaka S, Maki M, Yachi Y, Asumi M, et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA. 2009;301(19):2024–35.
  57. Myers J, Herbert W, Ribisl P, Franklin B. Is new science driving practice improvements and better patient outcomes? Applications for cardiac rehabilitation. Clin Invest Med. 2008;31(6):E400-7.
  58. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377–81.
  59. R B. PAPRICA – Physical activity promotion in primary care. Bewegungsförderung über die Arztpraxis Handbuch für Hausärztinnen und HausärzteRZTE. 2012(Überarbeitete deutsche Auflage 2012).
  60. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012;33(13):1635–701.
  61. Rognmo O, Hetland E, Helgerud J, Hoff J, Slordahl SA. High intensity aerobic interval exercise is superior to moderate intensity exercise for increasing aerobic capacity in patients with coronary artery disease. European journal of cardiovascular prevention and rehabilitation: official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology. 2004;11(3):216–22.
  62. Rognmo O, Moholdt T, Bakken H, Hole T, Molstad P, Myhr NE, et al. Cardiovascular risk of high- versus moderate-intensity aerobic exercise in coronary heart disease patients. Circulation. 2012;126(12):1436–40.
  63. Wisloff U, Stoylen A, Loennechen JP, Bruvold M, Rognmo O, Haram PM, et al. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation. 2007;115(24):3086–94.
  64. Meyer P, Gayda M, Juneau M, Nigam A. High-intensity aerobic interval exercise in chronic heart failure. Current heart failure reports. 2013;10(2):130–8.
  65. Weston KS, Wisloff U, Coombes JS. High-intensity interval training in patients with lifestyle-induced cardiometabolic disease: a systematic review and meta-analysis. Br J Sports Med. 2014;48(16):1227–34.
  66. Piepoli MF, Conraads V, Corra U, Dickstein K, Francis DP, Jaarsma T, et al. Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation. Eur J Heart Fail. 2011;13(4):347–57.
  67. Marzolini S, Oh PI, Brooks D. Effect of combined aerobic and resistance training versus aerobic training alone in individuals with coronary artery disease: a meta-analysis. Eur J Prev Cardiol. 2012;19(1):81–94.
  68. Bjarnason-Wehrens B, Mayer-Berger W, Meister ER, Baum K, Hambrecht R, Gielen S, et al. Recommendations for resistance exercise in cardiac rehabilitation. Recommendations of the German Federation for Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil. 2004;11(4):352–61.
  69. Spruit MA, Eterman RM, Hellwig VA, Janssen PP, Wouters EF, Uszko-Lencer NH. Effects of moderate-to-high intensity resistance training in patients with chronic heart failure. Heart. 2009;95(17):1399–408.
  70. Schmid JP, Anderegg M, Romanens M, Morger C, Noveanu M, Hellige G, et al. Combined endurance/resistance training early on, after a first myocardial infarction, does not induce negative left ventricular remodelling. Eur J Cardiovasc Prev Rehabil. 2008;15(3):341–6.
  71. Winkelmann ER, Chiappa GR, Lima CO, Viecili PR, Stein R, Ribeiro JP. Addition of inspiratory muscle training to aerobic training improves cardiorespiratory responses to exercise in patients with heart failure and inspiratory muscle weakness. Am Heart J. 2009;158(5):768 e1-7.
  72. Dall’Ago P, Chiappa GR, Guths H, Stein R, Ribeiro JP. Inspiratory muscle training in patients with heart failure and inspiratory muscle weakness: a randomized trial. J Am Coll Cardiol. 2006;47(4):757–63.
  73. Chow CK, Jolly S, Rao-Melacini P, Fox KA, Anand SS, Yusuf S. Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes. Circulation. 2010;121(6):750–8.
  74. Jolly K, Lip GY, Taylor RS, Raftery J, Mant J, Lane D, et al. The Birmingham Rehabilitation Uptake Maximisation study (BRUM): a randomised controlled trial comparing home-based with centre-based cardiac rehabilitation. Heart. 2009;95(1):36–42.
  75. Taylor RS, Dalal H, Jolly K, Zawada A, Dean SG, Cowie A, et al. Home-based versus centre-based cardiac rehabilitation. Cochrane Database Syst Rev. 2015;8:CD007130.
  76. Frederix I, Hansen D, Coninx K, Vandervoort P, Vandijck D, Hens N, et al. Effect of comprehensive cardiac telerehabilitation on one-year cardiovascular rehospitalization rate, medical costs and quality of life: A cost-effectiveness analysis. Eur J Prev Cardiol. 2016;23(7):674–82.
  77. Frederix I, Van Driessche N, Hansen D, Berger J, Bonne K, Alders T, et al. Increasing the medium-term clinical benefits of hospital-based cardiac rehabilitation by physical activity telemonitoring in coronary artery disease patients. Eur J Prev Cardiol. 2015;22(2):150–8.
  78. Diaz-Buschmann I, Jaureguizar KV, Calero MJ, Aquino RS. Programming exercise intensity in patients on beta-blocker treatment: the importance of choosing an appropriate method. Eur J Prev Cardiol. 2014;21(12):1474–80.
Zur Werkzeugleiste springen